Michele Romoli: What is The Optimal Treatment Strategy After Stroke While on DOAC?
Michele Romoli, Consultant Neurologist at “Bufalini” Hospital, shared on LinkedIn:
”What is the optimal treatment strategy after stroke while on DOAC?
In our latest meta-analysis just published in Neurology, we compared anticoagulation strategies after breakthrough ischemic stroke while on direct oral anticoagulants (DOACs) —a critical clinical challenge affecting thousands of patients worldwide.
KEY FINDINGS:
- Switching to warfarin increases risk of recurrent stroke (RR 1.80) and intracranial hemorrhage (RR 2.90) vs. continuing the same DOAC.
- DOAC-based strategies consistently outperformed warfarin.
- No significant benefit from DOAC-to-DOAC switching or adding antiplatelet therapy.
BOTTOM LINE: Keep patients on DOACs rather than switching to warfarin after breakthrough stroke.
STUDY SCOPE:
- 8 observational studies, 14,307 patients
- First comprehensive meta-analysis comparing all major anticoagulation strategies
- Observational evidence supporting DOAC continuation over warfarin switching
CLINICAL IMPACT:
This research challenges common clinical practices and provides evidence-based guidance for managing one of stroke neurology’s most challenging scenarios—what to do when stroke occurs despite “optimal” anticoagulation.
WHAT’S NEXT:
Excited to announce our upcoming TAILSWITCH study —a feasibility study to guide personalized anticoagulation decisions in breakthrough stroke patients leveraging on plasma DOAC levels.
GRATEFUL to collaborate with an exceptional international team of stroke researchers and neurologists who made this work possible.
Get in touch for TAILSWITCH, and randomize into available RCTs!
1. Carotid Implants for PreveNtion of STrokE ReCurrEnce from Large Vessel Occlusion in Atrial Fibrillation Patients Treated with Oral Anticoagulation (NCT05723926)
2. Early Closure of Left Atrial Appendage for Patients With Atrial Fibrillation and Ischemic Stroke Despite Anticoagulation Therapy (NCT05976685)
3. The Fourth Left Atrial Appendage Occlusion Study (NCT05963698)”
Read the full article here.
Article: Anticoagulation Strategies Following Breakthrough Ischemic Stroke While on Direct Anticoagulants
Authors: Michele Romoli, Maurizio Paciaroni, Nicola Marrone, Lina Palaiodimou, Valentina Tudisco, Claudia Faini, Aristeidis H. Katsanos et al.
Stay updated on all scientific advances with Hemostasis Today.
-
Feb 28, 2026, 17:03Investing in Education, Prevention, and Lifesaving Research for a Healthier Tomorrow – AHA
-
Feb 28, 2026, 17:00Pamela Gavin: 1 in 10 Americans Live With A Rare Disease – That Is Not Rare, That Is Public Health
-
Feb 28, 2026, 16:59Thomas Rocco Jr: Exploring Agentic AI in Cardiovascular Medicine
-
Feb 28, 2026, 16:50Rob Maloney: Normalcy Is Not A Small Thing In Rare Disease
-
Feb 28, 2026, 16:49Céline Chapelle: Evaluating 6-Month Risks of Recurrent VTE and Major Bleeding With Tinzaparin
-
Feb 28, 2026, 16:46Nicolas Hulscher: Nattokinase Dissolves 84% of Amyloid Microclots In Vitro
-
Feb 28, 2026, 16:46Alfonso Tafur: Preventing Post-Hospitalization Blood Clots Using Precision Tools and Systems
-
Feb 28, 2026, 16:39Anel Karisik: Do Antidepressants Influence Swallowing Recovery After Acute Ischemic Stroke?
-
Feb 28, 2026, 16:38Akinchan Bhardwaj: Targeting SBK2 for Selective Inflammasome Resolution in Atherosclerosis